Literature DB >> 15146036

The present and future management of malignant brain tumours: surgery, radiotherapy, chemotherapy.

R Rampling1, A James, V Papanastassiou.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15146036      PMCID： PMC1765659          DOI： 10.1136/jnnp.2004.040535

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  7 in total

Review 1.  Local control of gliomas: the next best step--a good step?

Authors:  M Westphal; A Giese
Journal:  Front Radiat Ther Oncol       Date:  1999

Review 2.  Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

Authors:  L A Stewart
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

Review 3.  The neurosurgeon as local oncologist: cellular and molecular neurosurgery in malignant glioma therapy.

Authors:  Ian F Dunn; Peter McL Black
Journal:  Neurosurgery       Date:  2003-06       Impact factor: 4.654

4.  Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

Authors:  J G Cairncross; K Ueki; M C Zlatescu; D K Lisle; D M Finkelstein; R R Hammond; J S Silver; P C Stark; D R Macdonald; Y Ino; D A Ramsay; D N Louis
Journal:  J Natl Cancer Inst       Date:  1998-10-07       Impact factor: 13.506

Review 5.  Modern aspects of radiation therapy for glial tumours of the brain.

Authors:  R Rampling
Journal:  Forum (Genova)       Date:  1998 Jul-Sep

6.  Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.

Authors:  Edward R Laws; Ian F Parney; Wei Huang; Fred Anderson; Angel M Morris; Anthony Asher; Kevin O Lillehei; Mark Bernstein; Henry Brem; Andrew Sloan; Mitchel S Berger; Susan Chang
Journal:  J Neurosurg       Date:  2003-09       Impact factor: 5.115

Review 7.  Non-cytotoxic therapies for malignant gliomas.

Authors:  Umberto Basso; Mario Ermani; Francesca Vastola; Alba A Brandes
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.506
  7 in total
  18 in total

1.  Post-operative diffusion weighted imaging as a predictor of posterior fossa syndrome permanence in paediatric medulloblastoma.

Authors:  Felicia H Z Chua; Ady Thien; Lee Ping Ng; Wan Tew Seow; David C Y Low; Kenneth T E Chang; Derrick W Q Lian; Eva Loh; Sharon Y Y Low
Journal:  Childs Nerv Syst       Date:  2017-02-11       Impact factor: 1.475

2.  Knocking down the expression of SYF2 inhibits the proliferation of glioma cells.

Authors:  Jun Guo; Lixiang Yang; Jianfeng Huang; Xiancheng Liu; Xiaojun Qiu; Tao Tao; Yonghua Liu; Xiaojuan He; Na Ban; Shaochen Fan; Guan Sun
Journal:  Med Oncol       Date:  2014-07-02       Impact factor: 3.064

3.  Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience.

Authors:  Monica Anselmi; Alessia Catalucci; Valentina Felli; Valentina Vellucci; Alessandra Di Sibio; Giovanni Luca Gravina; Mario Di Staso; Ernesto Di Cesare; Carlo Masciocchi
Journal:  Neuroradiol J       Date:  2017-01-01

4.  Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors.

Authors:  Nail Bulakbasi; Murat Kocaoglu; Anar Farzaliyev; Cem Tayfun; Taner Ucoz; Ibrahim Somuncu
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

Review 5.  Chemotherapy wafers for high grade glioma.

Authors:  Michael G Hart; Robert Grant; Ruth Garside; Gabriel Rogers; Margaret Somerville; Ken Stein
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

6.  Bex2 is critical for migration and invasion in malignant glioma cells.

Authors:  Xiuping Zhou; Xuebin Xu; Qingming Meng; Jinxia Hu; Tongle Zhi; Qiong Shi; Rutong Yu
Journal:  J Mol Neurosci       Date:  2012-08-03       Impact factor: 3.444

7.  Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics.

Authors:  Jun Liang; Xianli Zhang; Shao Xie; Xiuping Zhou; Qiong Shi; Jinxia Hu; Weifeng Wang; Weifeng Qi; Rutong Yu
Journal:  Med Oncol       Date:  2014-02-27       Impact factor: 3.064

8.  Role of advanced MR imaging modalities in diagnosing cerebral gliomas.

Authors:  T Scarabino; T Popolizio; F Trojsi; G Giannatempo; S Pollice; N Maggialetti; A Carriero; A Di Costanzo; G Tedeschi; U Salvolini
Journal:  Radiol Med       Date:  2008-12-11       Impact factor: 3.469

Review 9.  Temozolomide for high grade glioma.

Authors:  Michael G Hart; Ruth Garside; Gabriel Rogers; Ken Stein; Robin Grant
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

Review 10.  Whole brain radiation-induced cognitive impairment: pathophysiological mechanisms and therapeutic targets.

Authors:  Yong Woo Lee; Hyung Joon Cho; Won Hee Lee; William E Sonntag
Journal:  Biomol Ther (Seoul)       Date:  2012-07       Impact factor: 4.634
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.